Location: Home
  • search
  • go
  • Relate News
  • 2/13/2025Navigating Cross-Border Pharma Deals: Key Trends and Lessons Out of Ch...
  • 2/13/2025Global PE Firms Compete to Acquire Majority Stake in Gland Pharma from...
  • 2/13/2025China's Pharmaceutical Market Shrinks in 2024 Amid Structural Shifts
  • 2/13/2025Over 30 Listed Chinese Pharma Firms Report First-Time Losses as 257 Co...
  • 2/13/2025GSK's Mepolizumab Submits New COPD Indication for Market Approval in C...
  • 2/12/2025Merck Registers Kelun's Nectin-4 ADC MK-3120 and Initiates Phase 1 Tri...
  • 2/12/2025FDA Issues Warning Letters to Two Chinese API Manufacturers
  • 2/12/2025CSPC Granted NMPA Approval for Herpes Zoster mRNA Vaccine Clinical Tri...
  • 2/12/2025Lion TCR's Liocyx-M004 Receives FDA IND Approval for Phase 2 Trial
  • 2/12/2025The Drug Industry Is Having Its Own DeepSeek Moment (WSJ)
  • 2/12/2025China Biopharma Tracker – January 2025 (PharmaDJ)
  • 2/11/2025Pharmaceuticals Become a Battlefield in the Sino-US Trade War (AsiaTim...
  • 2/11/2025BioKin Pharma's HER2 ADC BL-M07D1 Advances to Phase III in China
  • 2/11/2025Novo Nordisk Reports Strong Growth in China for 2024, Driven by GLP-1 ...
  • 2/11/2025Bio-Thera Enters License Pact with Intas Pharma for Simponi® Biosim...
  • 2/11/2025China's Digital Health Sector Poised for Growth Amid Data Security Con...
  • 2/11/2025JNJ Receives Approval in China for Two Novel BsAbs
  • 2/10/2025NMPA Approves Sinocelltech's Anti-PD-1 Antibody Finotonlimab
  • 2/10/2025Kelun-Biotech's Cetuximab Biosimilar Receives NMPA Approval for First-...
  • 2/10/2025CDE Issues the Technical Guidelines for Writing Biosimilar Drug Packag...
  • 2/7/2025AstraZeneca Reports Strong 2024 Performance Amid China Sales Decline a...
  • 2/7/2025NMPA Announces Package Insert Revision of Gemifloxacin Mesylate Tablet...
  • 2/7/2025Henlius Biotech's Lung Cancer Drug Secures EU Approval
  • 2/7/2025Henlius and Dr. Reddy's Ink Licensing Deal for Daratumumab Biosimilar ...
  • 2/7/2025Recent Executive Moves
  • 2/7/2025Chinese Biotech Firms Cash In On Promising Drug Discoveries Via Licens...
  • 2/7/2025Rapid Trials Prompt Deals Rush for Chinese ‘Super Me-Too’ Drugs (FT)
  • 2/7/2025China's Biopharma Mirrors EV Success (The China Academy)
  • 2/6/2025Merck Halts HPV Vaccine Supply: What It Says about China Market (EGGI)
  • 2/5/2025Trump's Tariffs Threaten Big Pharma With Higher Costs and Slimmer Marg...
  • Page:11/359 Total number of articles:10758: [First][<<] [9] [10] [11] [12] [13] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group